Evidence map›Paper›PMID 10416994›Full record

ReviewBrain pathology (Zurich, Switzerland)1999

Establishment and properties of neural stem cell clones: plasticity in vitro and in vivo.

A L Vescovi, E Y Snyder

Open access · greenAbstract readReview
In one paragraph

Review in Brain pathology (Zurich, Switzerland), 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 176 citations in OpenAlex.

  1. Article
  2. Article
  3. Neuroprotection ofMolecules (Basel, Switzerland) · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  9. Article
  10. Review
  11. Article
  12. Neural stem cell transplantation as a therapeutic approach for treating lysosomal storage diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2011
    Review
  13. Article
  14. Mechanotransduction: tuning stem cells fate.Journal of functional biomaterials · 2011
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Stem cells and neurological diseases.Cell proliferation · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

A L VescoviLaboratory of Neuropharmacology, National Neurological Institute C. Besta, Milan, Italy.
E Y Snyder
Boston Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of the basic physiology of the neural precursors generated during brain development is driven by two inextricably linked goals. First, such knowledge is instrumental to our understanding of how the high degree of cellular complexity of the mature central nervous system (CNS) is generated, and how to dissect the steps of proliferation, fate commitment, and differentiation that lead early pluripotent neural progenitors to give rise to mature CNS cells. Second, it is hoped that the isolation, propagation, and manipulation of brain precursors and, particularly, of multipotent neural stem cells (NSCs), will lead to therapeutic applications in neurological disorders. The debate is still open concerning the most appropriate definition of a stem cell and on how it is best identified, characterized, and manipulated. By adopting an operational definition of NSCs, we review some of the basic findings in this area and elaborate on their potential therapeutic applications. Further, we discuss recent evidence from our two groups that describe, based on that rigorous definition, the isolation and propagation of clones of NSCs from the human fetal brain and illustrate how they have begun to show promise for neural cell replacement and molecular support therapy in models of degenerative CNS diseases. The extensive propagation and engraftment potential of human CNS stem cells may, in the not-too-distant-future, be directed towards genuine clinical therapeutic ends, and may open novel and multifaceted strategies for redressing a variety of heretofore untreatable CNS dysfunctions.

Indexed as

AnimalsBrainBrain Tissue TransplantationCell Culture TechniquesCell DifferentiationCell LineCell LineageCell SeparationClone CellsEmbryo, MammalianFetusHumansMiceNeuronal PlasticityNeuronsRats

Identifiers

PMID10416994
PMCPMC8098170
OpenAlexW2102426962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.